Bank of Montreal
AVNR

Bank of Montreal’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bank of Montreal’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-680
Closed -$12K – 4421
2014
Q4 		$12K Hold
680
– – ﹤0.01% 3518
2014
Q3 		$8K Sell
680
-2,830
-81% -$19.3K ﹤0.01% 3720
2014
Q2 		$20K Buy
+3,510
New +$16.2K ﹤0.01% 3598

Bank of Montreal's AVNR Position: Q1 2015 in Review

Bank of Montreal sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 680 shares — an estimated $12K sold.

Bank of Montreal first reported a position in AVNR in Q2 2014 and held it in 3 quarters. The position peaked at $20K in Q2 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Bank of Montreal reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Bank of Montreal sold 680 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $12K.
  • Bank of Montreal first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2014 and held it in 3 quarters.
  • Bank of Montreal's AVANIR PHARMACEUTICALS, INC CL A position peaked at $20K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Bank of Montreal's 13F filing for Q1 2015, filed 13 May 2015.